Effect of 4,4'-biphenylenebis-((2-oxoethylene)-bis-(2,2-diethoxyethyl))dimethylammonium dibromide (DMAE) on accumulation and nicotine-induced release of norepinephrine in the heart.
D000818:Animals; D001713:Biphenyl Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D001966:Bromine / Q000008:administration & dosage / Q000494:pharmacology; D003042:Cocaine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006321:Heart / Q000187:drug effects*; D066298:In Vitro Techniques; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D009538:Nicotine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000644:Quaternary Ammonium Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D013997:Time Factors; D014316:Tritium
D001713:Biphenyl Compounds; D000644:Quaternary Ammonium Compounds; D014316:Tritium; D009538:Nicotine; D003042:Cocaine; D001966:Bromine; D009638:Norepinephrine